Progression risk among responders to PD-1/PD-L1 blockade is primarily stratified by response depth: A nationwide cohort study of 2127 patients with melanoma, RCC, and NSCLC. - Andersen R; Jespersen MS; Presti M; Bjornhart B; Østby AC; Darras AKM; Garitaonaindia Y; Ruhlmann CH; Frank MS; Schmidt H; Friis RB; Guldbrandt LM; et al. (European journal of cancer (Oxford, England : 1990), 2026)